# Boston Scientific Corporation (BSX) — Q2-2021 Earnings Results

**Report date:** 2021-07-27 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q2-2021

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Up 3.5%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.40 | N/A | +7.24% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's performance. They emphasized their commitment to innovation and growth.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They highlighted ongoing efforts to enhance product offerings and market presence.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 3.5% increase. Investors may view the EPS beat as a sign of the company's resilience and potential for future growth. However, the lack of revenue data and guidance leaves some uncertainty about overall performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q2-2021_